)
Homegrown drug major Zydus Cadila has set a target of clocking a consolidated turnover of over Rs 10,000 crore by FY'16.
"We will have a revenue of Rs 10,000 crore in FY16. We closed last fiscal with a revenue of Rs 7,208 crore," Zydus Cadila Chief Operating Officer and Executive Director Ganesh Nayak said here.
The Ahmedabad-based company has planned a capital expenditure of Rs 450 crore this fiscal. It has presence in the US, the European Union, Brazil, Mexico and exports generate half the revenue.
Meanwhile, its consumer products arm Zydus Wellness, which makes the Sugar Free, is looking at a foray into adjacent categories like jams and biscuits in the future. The sweetener brand Sugar Free has a 93 per cent market share in the sugar substitute category that is estimated at Rs 250 crore and growing at 12 per cent.
